ARAY on Nasdaq

ACCURAY INC

Price unavailable

Last updated Oct 16, 2026.

Overview

$401.9MRevenue, fiscal 20262
-$49.2MNet income, fiscal 20262

Compare with MIMEDX GROUP, INC., CryoLife or TACTILE SYSTEMS TECHNOLOGY INC, or pick any stock.

  • TickerARAY on Nasdaq
  • IndustrySurgical & Medical Instruments & Apparatus
  • HeadquartersDE
  • Incorporated inDE3
  • Business address1240 Deming Way, Madison, Wi 537173
  • Filer categoryAccelerated filer, Smaller reporting company3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

27.7%Gross margin2
-6.6%Operating margin2
-12.2%Net margin2
-12.3%Revenue growth, 20262
-118.0%Return on equity2
3.51×Debt to equity2
-$12.8MFree cash flow2

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Service brought in 57% of the revenue ACCURAY INC broke down this way in fiscal 2026.

  1. Service$229.2M257%up 4% from 2025
  2. Product$172.7M243%down 27% from 2025
Products and services by year
Products and services202420252026
Service$212.4M$220.9M$229.2M
Product$234.2M$237.6M$172.7M

Regions

Eimea brought in 38% of the revenue ACCURAY INC broke down this way in fiscal 2026.

  1. Eimea$150.9M238%up 5% from 2025
  2. Americas$90.0M222%up 1% from 2025
  3. China$68.1M217%down 45% from 2025
  4. Asia Pacific$48.7M212%up 3% from 2025
  5. Japan$44.3M211%down 17% from 2025
Regions by year
Regions202420252026
Eimea$168.6M$144.3M$150.9M
Americas$90.2M$88.8M$90.0M
China$103.4M$124.5M$68.1M
Asia Pacific$28.7M$47.4M$48.7M
Japan$55.7M$53.6M$44.3M

Where the money goes

Where each dollar of revenue went, fiscal 2026

  • Cost of revenue72¢$290.5M
  • Research and development9¢$37.8M
  • Other costs18¢$71.8M
  • Income tax0¢$1.9M

Out of $401.9M in revenue.2 The company lost money this year.

Financial statements

Revenue456782$401.9M in 2026−4% since 2019
0$200.0M$400.0M$600.0M2019: $418.8M$418.8M20192020: $382.9M$382.9M2020−9%2021: $396.3M$396.3M2021+3%2022: $429.9M$429.9M2022+8%2023: $447.6M$447.6M2023+4%2024: $446.6M$446.6M2024−0%2025: $458.5M$458.5M2025+3%2026: $401.9M$401.9M2026−12%
Gross profit456782$111.5M in 2026−31% since 2019
0$50.0M$100.0M$150.0M$200.0M2019: $162.7M$162.7M20192020: $149.7M$149.7M2020−8%2021: $159.5M$159.5M2021+7%2022: $160.0M$160.0M2022+0%2023: $154.0M$154.0M2023−4%2024: $142.9M$142.9M2024−7%2025: $147.0M$147.0M2025+3%2026: $111.5M$111.5M2026−24%
Operating income456782-$26.4M in 2026
-$40.0M-$20.0M0$20.0M$40.0M2019: $583.0K$583.0K20192020: $12.5M$12.5M2020+2051%2021: $22.2M$22.2M2021+77%2022: $8.1M$8.1M2022−63%2023: $2.4M$2.4M2023−71%2024: $504.0K$504.0K2024−79%2025: $7.8M$7.8M2025+1455%2026: -$26.4M-$26.4M2026
Net income456782-$49.2M in 2026+199% since 2019
-$60.0M-$40.0M-$20.0M0$20.0M2019: -$16.4M-$16.4M20192020: $3.8M$3.8M20202021: -$6.3M-$6.3M20212022: -$5.3M-$5.3M2022−15%2023: -$9.3M-$9.3M2023+74%2024: -$15.5M-$15.5M2024+68%2025: -$1.6M-$1.6M2025−90%2026: -$49.2M-$49.2M2026+2992%

Every line of the income statement in the latest annual report, as filed.2

Period ending2026-06-302025-06-30
Gross profit$111.5M$147.0M
Research and development$37.8M$47.9M
Selling and marketing$38.6M$43.3M
General and administrative$45.4M$47.9M
Restructuring$16.2M$0
Total operating expenses$137.9M$139.1M
Income (loss) from operations-$26.4M$7.8M
Income from equity method investment$1.1M$4.7M
Interest expense-$32.9M-$13.0M
Gain on extinguishment of debt$0$1.5M
IEEPA refund financing costs-$2.4M$0
Gain (loss) from change in fair value of warrant liability$8.4M-$499.0K
Other income, net$5.0M$559.0K
Income (loss) before provision for income taxes-$47.2M$1.1M
Provision for income taxes$1.9M$2.7M
Net loss-$49.2M-$1.6M
Net loss per share - basic and diluted (in dollars per share)-$0.40-$0.02
Basic and diluted (in shares)122.6M shares102.8M shares
Unrealized gain from cash flow hedges, net of reclassifications$1.6M$0
Foreign currency translation adjustment-$3.2M$1.6M
Change in defined benefit pension obligation-$42.0K$828.0K
Comprehensive income (loss)-$50.9M$794.0K
Revenue from Contract with Customer$401.9M$458.5M
Cost of Revenue$290.5M$311.5M

Compare ACCURAY INC with another company

Recent filings

  1. Oct 13, 20268-K
  2. Oct 7, 20263 PRIMARY DOCUMENT
  3. Oct 7, 20264 PRIMARY DOCUMENT
  4. Oct 6, 20268-K
  5. Oct 1, 20264 PRIMARY DOCUMENT
  6. Sep 18, 2026DEFA14A
  7. Sep 11, 2026424B3
  8. Sep 11, 2026EFFECT
  9. Sep 9, 2026S-3/A
  10. Sep 2, 20264 OWNERSHIP DOCUMENT
  11. Sep 2, 2026SCHEDULE 13D/A
  12. Aug 27, 202610-K
  13. Aug 24, 2026DEF 14A
  14. Aug 21, 2026S-3/A
  15. Aug 19, 20268-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1